Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on: January 23,2024

Study finds younger kidney cancer survivors at significant risk for heart problems

byVirginia Commonwealth UniversityCredit: Pixabay/CC0 Public DomainNew research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a si

Updated on:January 23,2024

Pill halves risk of death in type of lung cancer

Credit: Pixabay/CC0 Public DomainA pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial res

Updated on: February 03,2024

Pill halves risk of death in type of lung cancer

Credit: Pixabay/CC0 Public DomainA pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial res

Updated on:February 03,2024

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on: January 29,2024

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on:January 29,2024

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on: April 07,2024

Race, insurance status linked to job loss after breast cancer

by Neil Schoenherr,Washington University in St. LouisCredit: Washington University in St. LouisJob loss following early-stage breast cancer diagnosis is associated with race and insurance status

Updated on:April 07,2024

Expert discusses the deeper complexities of cancer

by University of MichiganCredit: CC0 Public DomainGeeta Mehta studies cancer not simply as masses of cells but as structured organs with multiple cell types that communicate with each other and i

Updated on: April 01,2024

Expert discusses the deeper complexities of cancer

by University of MichiganCredit: CC0 Public DomainGeeta Mehta studies cancer not simply as masses of cells but as structured organs with multiple cell types that communicate with each other and i

Updated on:April 01,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on: April 01,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on:April 01,2024

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me

Updated on: April 01,2024

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me

Updated on:April 01,2024

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of

Updated on: September 10,2024

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of

Updated on:September 10,2024

Study demonstrates antitumor action of substance present in Brazilian green propolis

FEBRUARY 7, 2024byFAPESPLDH assay representing the percentage of membrane integrity damage obtained for fibroblast (A) and glioblastoma (B) cell lines, after 24 h incubation, exposed to 0, 1, 10

Updated on: March 27,2024

Study demonstrates antitumor action of substance present in Brazilian green propolis

FEBRUARY 7, 2024byFAPESPLDH assay representing the percentage of membrane integrity damage obtained for fibroblast (A) and glioblastoma (B) cell lines, after 24 h incubation, exposed to 0, 1, 10

Updated on:March 27,2024

Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres

Updated on: March 08,2024

Transplant medication matters for controlling cancer risk

by University of QueenslandCredit: University of QueenslandResearch reveals organ transplant recipients could reduce their risk of developing secondary skin cancer by changing their immunosuppres

Updated on:March 08,2024

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on: January 04,2024

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainOver the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment fo

Updated on:January 04,2024

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (

Updated on: January 04,2024

Experimental ovarian cancer diagnostic could lead to new precision oncology approach

byFred Hutchinson Cancer CenterIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (

Updated on:January 04,2024